Skip to content
2000
Volume 9, Issue 2
  • ISSN: 1574-888X
  • E-ISSN: 2212-3946

Abstract

Bladder cancer stem cell research is rapidly expanding based on the knowledge of cancer stem cells from various cancer types and normal stem cells as models. In various cancer types, cancer stem cells have been implicated in therapeutic resistance and relapse after initial therapy. Understanding how cancer stem cells differ from bulk cancer cells and how cancer stem cells contribute to relapse and resistance are essential to develop novel therapeutics to target cancer stem cells effectively. Here we review the latest information on bladder cancer stem cells, their biological characteristics, including their response to treatment, recurrence, immune context and technical problems encountered in bladder cancer stem cell research.

Loading

Article metrics loading...

/content/journals/cscr/10.2174/1574888X08666131113123051
2014-03-01
2025-10-28
Loading full text...

Full text loading...

/content/journals/cscr/10.2174/1574888X08666131113123051
Loading

  • Article Type:
    Research Article
Keyword(s): Blebbishields; c-Met; cancer stem cells; CD44; neutrophils; T-cells; VEGFR2
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test